For the quarter ending 2026-03-31, NYT had -$69,598K decrease in cash & cash equivalents over the period. $81,513K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 87,922 | 129,838 | 199,405 | 195,059 |
| Depreciation and amortization | 20,563 | 20,892 | 21,341 | 21,396 |
| Amortization of right-of-use asset | 2,762 | 2,953 | 2,524 | 2,336 |
| Stock-based compensation expense | 19,270 | 20,520 | 18,507 | 17,803 |
| Multiemployer pension plan liability adjustment | 0 | 1,486 | 0 | 0 |
| Impairment charges | - | 2,858 | - | - |
| Gain from joint ventures | - | 0 | - | - |
| Change in long-term retirement benefit obligations | -3,413 | -2,476 | -3,094 | -2,591 |
| Contingent consideration fair value adjustment | - | - | -1,177 | - |
| Fair market value adjustment on life insurance products | - | 400 | - | - |
| Other net | -719 | -2,039 | 2,394 | -1,562 |
| Accounts receivable net | -55,966 | 86,734 | -6,989 | 18,564 |
| Other assets | 735 | 315 | -7,385 | 2,808 |
| Accounts payable, accrued payroll and other liabilities | -98,641 | 69,695 | 61,289 | 16,923 |
| Unexpired subscriptions | 8,201 | 9,683 | 7,928 | -3,693 |
| Other noncurrent assets and liabilities | -1,060 | 11 | -1,875 | -1,453 |
| Net cash provided by operating activities | 92,236 | 164,155 | 207,608 | 113,638 |
| Purchases of marketable securities | 129,210 | 179,317 | 173,028 | 132,095 |
| Maturities of marketable securities | 116,696 | 113,612 | 78,392 | 98,374 |
| Proceeds from/(purchases of) investments | - | -246 | - | - |
| Capital expenditures | 10,723 | 6,533 | 7,878 | 10,336 |
| Other net | -559 | 207 | -5,479 | -315 |
| Net cash used in investing activities | -22,678 | -72,199 | -97,035 | -43,742 |
| Dividends paid | 30,387 | 29,290 | 29,403 | 29,601 |
| Payment of contingent consideration | - | 0 | 431 | 0 |
| Purchase of noncontrolling interest | - | 0 | - | - |
| Repurchases | 56,348 | 55,461 | 27,319 | 23,604 |
| Share-based compensation tax withholding | 52,421 | 663 | 1,821 | 1,277 |
| Net cash used in financing activities | -139,156 | -85,414 | -58,974 | -54,482 |
| Net decrease in cash, cash equivalents and restricted cash | -69,598 | 6,542 | 51,599 | 15,414 |
| Effect of exchange rate changes on cash | -389 | -290 | -140 | - |
| Cash, cash equivalents and restricted cash at the beginning of the period | 270,461 | 264,209 | 213,857 | - |
| Cash, cash equivalents and restricted cash at the end of the period | 200,474 | 270,461 | 264,209 | - |